Press Release, Numerator, Nov 2023
GLP-1 medications were originally developed for type 2 diabetes , but are now also approved for people with obesity or weight-related health conditions
The National Family Health Survey (NFHS-4, 2015-16) reported that 20.7% of women and 18.6% of men in the 15-49 age group were overweight or obese, underscoring the urgent need for effective weight-loss solutions
Bi nh gi chuyn su t Whey Tt s gip bn nm r c ch hot ng, so snh cc dng bo ch v hm lng, ng thi hng dn cch kim tra ngun gc sn phm nhp khu chnh hng
Kushwaha R, Li Y, Makarava N, Pandit NP, Molesworth K, Birukov KG, et al
M.DiLeoneR